Prognostic impact of micromegakaryocytes in primary myelodysplastic syndromes. Saumell S, Fernandez-Serrano M, Mesa A, Lopez-Cadenas F, et al. Leuk Lymphoma 2022;63:1227-1235.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Saumell S, Fernandez-Serrano M, Mesa A, Lopez-Cadenas F, et al. Prognostic impact of micromegakaryocytes in primary myelodysplastic syndromes. Leuk Lymphoma 2022;63:1227-1235.
PMID: 34969346